glp 1 and osteoporosis A study presented at the #AAOS2026 Annual Meeting revealed GLP-1 receptor agonist use was associated with a 29% higher risk of after five years. As these medications become more widely used 🦴GLP-1s can be powerful tools….but

Together, these findings highlight the need for further studies investigating how peripheral and central alterations interact in VPA-induced neurodevelopmental impairment (Bambini-Junior et al

What surprises them is that a scar they have had for three years starts fading, or a patch of pigmentation that has not moved in two years begins to clear

IV delivery makes all the difference

Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality

Work in BAs laboratory is supported by the Faculty of Medicine, Lund University, Lund, Sweden

Valproic acid can pass into breast milk